Medicine
Pregabalin 75 mg capsule
Pregabalin 75 mg capsule is a generic prescription medicine for oral use, made by 43 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Key facts
- Active ingredient (INN)
- Pregabalin
- Brand
- Sold under the generic name
- Strength
- 75 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 30 capsules, 90 capsules and 214 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaCiplaIndiaIndoco RemediesIndiaNovadoz PharmaceuticalsIndiaFourrts (India) LaboratoriesIndiaCadila PharmaceuticalsIndia43 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N02BF02 Pregabalin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 July 2019
- Identifiers
- RxCUI 483450, 483438, 483440 +5DailyMed set ID afc89689-bea9-92ec-e053-2995a90a7f21, 580955ba-86f6-4e86-b0fa-dd44e8828b0e, 241c4b7e-f719-4828-8639-ea613b8a6583 +37NDC 80425-0030, 82804-207, 31722-612 +37Application ANDA209357, ANDA206912, ANDA212865 +21
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 43 labelers. The register lists 217 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 carton | 46708-121-10 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 30 capsule in 1 bottle | 46708-121-30 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 46708-121-90 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 1000 capsule in 1 bottle | 46708-121-91 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 100 capsule in 1 carton | 62332-121-10 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 30 capsule in 1 bottle | 62332-121-30 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 62332-121-90 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 1000 capsule in 1 bottle | 62332-121-91 | Alembic PharmaceuticalsIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 69097-679-05 | CiplaIndia | 10 January 2020 |
| 90 capsule in 1 bottle | 69097-956-05 | CiplaIndia | 19 July 2019 |
| 500 capsule in 1 bottle | 69097-956-12 | CiplaIndia | 19 July 2019 |
| 500 capsule in 1 bottle | 67877-464-05 | Ascend LaboratoriesIndia | 21 July 2019 |
| 30 capsule in 1 bottle | 67877-464-30 | Ascend LaboratoriesIndia | 21 July 2019 |
| 1 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-464-33 | Ascend LaboratoriesIndia | 21 July 2019 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-464-38 | Ascend LaboratoriesIndia | 21 July 2019 |
| 90 capsule in 1 bottle | 67877-464-90 | Ascend LaboratoriesIndia | 21 July 2019 |
| 100 capsule in 1 bottle | 65862-760-01 | Aurobindo PharmaIndia | 29 March 2023 |
| 500 capsule in 1 bottle | 65862-760-05 | Aurobindo PharmaIndia | 29 March 2023 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-760-78 | Aurobindo PharmaIndia | 29 March 2023 |
| 90 capsule in 1 bottle | 65862-760-90 | Aurobindo PharmaIndia | 29 March 2023 |
| 90 capsule in 1 bottle | 71209-034-04 | Cadila PharmaceuticalsIndia | 13 July 2023 |
| 500 capsule in 1 bottle | 31722-612-05 | Camber PharmaceuticalsIndia | 8 October 2019 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 31722-612-31 | Camber PharmaceuticalsIndia | 8 October 2019 |
| 60 capsule in 1 bottle | 31722-612-60 | Camber PharmaceuticalsIndia | 8 October 2019 |
| 90 capsule in 1 bottle | 31722-612-90 | Camber PharmaceuticalsIndia | 8 October 2019 |
| 500 capsule in 1 bottle | 43598-293-05 | Dr. Reddy's LaboratoriesIndia | 19 July 2019 |
| 5 blister pack in 1 carton / 10 capsule in 1 blister pack | 43598-293-66 | Dr. Reddy's LaboratoriesIndia | 19 July 2019 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 43598-293-78 | Dr. Reddy's LaboratoriesIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 43598-293-90 | Dr. Reddy's LaboratoriesIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 82968-008-02 | Fourrts (India) LaboratoriesIndia | 24 February 2026 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 82968-008-04 | Fourrts (India) LaboratoriesIndia | 24 February 2026 |
| 1000 capsule in 1 bottle | 14445-123-00 | Indoco RemediesIndia | 6 September 2024 |
| 100 capsule in 1 blister pack | 14445-123-10 | Indoco RemediesIndia | 17 May 2024 |
| 90 capsule in 1 bottle | 14445-123-90 | Indoco RemediesIndia | 17 May 2024 |
| 90 capsule in 1 bottle | 33342-167-10 | Macleods PharmaceuticalsIndia | 13 November 2024 |
| 90 capsule in 1 bottle | 25000-181-07 | Marksans PharmaIndia | 1 August 2022 |
| 100 blister pack in 1 carton / 10 capsule in 1 blister pack | 72205-013-06 | Novadoz PharmaceuticalsIndia | 19 July 2019 |
| 90 capsule in 1 bottle | 72205-013-90 | Novadoz PharmaceuticalsIndia | 19 July 2019 |
| 1000 capsule in 1 bottle | 72205-013-99 | Novadoz PharmaceuticalsIndia | 19 July 2019 |
| 100 capsule in 1 bottle | 47335-688-08 | Sun Pharmaceutical IndustriesIndia | 4 December 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pregabalin 75 mg capsule.
Other strengths and forms of Pregabalin
Clinical summary
Pregabalin is a prescription medicine indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, among other approved uses. It is available as capsules, extended-release tablets and oral solution. MedsAcross supplies Pregabalin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PregabalinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lyrica prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
- Lyrica: European public assessment report (EPAR) · European Medicines Agency
- Pregabalin Viatris Pharma (previously Pregabalin Pfizer): European public assessment report (EPAR) · European Medicines Agency
Need Pregabalin 75 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.